Clinical Trial Update: Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) [NA]

View source ↗

Summary

The update summarizes a completed clinical trial comparing ondansetron to palonosetron as antiemetic regimens before highly emetogenic chemotherapy, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Ondansetron (ondansetron)
• Palonosetron (palonosetron)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Malignant Neoplasm | NA | Status: COMPLETED | Results posted: 2013-10-07